Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Foley

Showing results (661-670 of 679) with videos related to

Pageof 68
Sort By:
Science Advances|June 19, 2026
Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAPNazli Robin, Nicole G Barra, Kevin P Foley, et al.
Cell Reports. Medicine|October 8, 2021
Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiotaBasma A Ahmed, Frank J Ong, Nicole G Barra, et al.
Annals of Surgical Oncology|September 14, 2024
ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
Journal of Medicinal Chemistry|April 1, 2016
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based DiscoveryThomas G Davies, William E Wixted, Joseph E Coyle, et al.
Annals of Surgical Oncology|October 26, 2024
ASO Visual Abstract: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma Following Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
Annals of Surgical Oncology|August 22, 2024
Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
The New England Journal of Medicine|December 19, 2003
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasiaJohn D McConnell, Claus G Roehrborn, Oliver M Bautista, et al.
JAMA Surgery|May 27, 2026
Portal-Venous Hypothermic Oxygenated Perfusion for Liver Transplant: A Randomized Clinical TrialDavid J Reich, Shennen Mao, Sangeeta Satish, et al.
Annals of Surgical Oncology|October 29, 2024
ASO Visual Abstract: Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular CarcinomaFrances J Bennett, Jessica M Keilson, Michael K Turgeon, et al.
EMBO Molecular Medicine|February 11, 2015
Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistanceEmmanuel Denou, Karine Lolmède, Lucile Garidou, et al.
Pageof 68

Showing results (661-670 of 679) with videos related to

Sort By:
Pageof 68
Science Advances|June 19, 2026
Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAPNazli Robin, Nicole G Barra, Kevin P Foley, et al.
Cell Reports. Medicine|October 8, 2021
Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiotaBasma A Ahmed, Frank J Ong, Nicole G Barra, et al.
Annals of Surgical Oncology|September 14, 2024
ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
Journal of Medicinal Chemistry|April 1, 2016
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based DiscoveryThomas G Davies, William E Wixted, Joseph E Coyle, et al.
Annals of Surgical Oncology|October 26, 2024
ASO Visual Abstract: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma Following Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
Annals of Surgical Oncology|August 22, 2024
Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver TransplantationAbraham J Matar, Kailey M Oppat, Frances J Bennett, et al.
The New England Journal of Medicine|December 19, 2003
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasiaJohn D McConnell, Claus G Roehrborn, Oliver M Bautista, et al.
JAMA Surgery|May 27, 2026
Portal-Venous Hypothermic Oxygenated Perfusion for Liver Transplant: A Randomized Clinical TrialDavid J Reich, Shennen Mao, Sangeeta Satish, et al.
Annals of Surgical Oncology|October 29, 2024
ASO Visual Abstract: Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular CarcinomaFrances J Bennett, Jessica M Keilson, Michael K Turgeon, et al.
EMBO Molecular Medicine|February 11, 2015
Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistanceEmmanuel Denou, Karine Lolmède, Lucile Garidou, et al.
Pageof 68